These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 6323597)
21. [Tumor selective drug delivery with lipid contrast medium (smancs/lipiodol): sustained antitumor effect, enhanced diagnostic value and quantification of dosage regimen]. Maeda H; Konno T; Iwai K; Maki S; Tashiro S Gan To Kagaku Ryoho; 1984 Apr; 11(4):814-26. PubMed ID: 6326681 [TBL] [Abstract][Full Text] [Related]
22. [Histological effect of SMANCS/LPD therapy in renal cell carcinoma]. Suzuki T; Kobayashi M; Nakamura T; Takahashi O; Imai K; Yamanaka H; Suzuki K; Konno T; Maeda H Nihon Gan Chiryo Gakkai Shi; 1987 Oct; 22(9):2210-7. PubMed ID: 2833546 [No Abstract] [Full Text] [Related]
23. [Intra-arterial infusion of SMANCS for treatment of patients with hepatocellular carcinoma--adverse reactions and complications]. Sakaguchi T; Yoshimatsu S; Sagara K; Yamashita Y; Takahashi M Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():64-9. PubMed ID: 9512690 [TBL] [Abstract][Full Text] [Related]
24. [Computed tomography after administration of SMANCS-lipiodol to liver cancers]. Maki S; Konno T; Iwai K; Uchida M; Tashiro S; Miyauchi Y; Maeda H Nihon Gan Chiryo Gakkai Shi; 1984 Aug; 19(7):1443-9. PubMed ID: 6097616 [No Abstract] [Full Text] [Related]
25. [Tumor-targeted chemotherapy with lipid contrast medium and macro molecular anticancer agents theoretical considerations and clinical outcome]. Maeda H; Konno T Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 2):773-82. PubMed ID: 2985005 [TBL] [Abstract][Full Text] [Related]
26. [Evaluation of transcatheter hepatic segmental or subsegmental infusion of SMANCS for treatment of hepatocellular carcinoma]. Inoue Y; Tomoda K; Oi H; Nakamura H Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():56-63. PubMed ID: 9512689 [TBL] [Abstract][Full Text] [Related]
27. [Prevention of hepatic metastases in rabbits by administration of an oily anticancer agent into the portal vein]. Yamasaki K; Konno T; Miyauchi Y; Maeda H Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 1):1224-8. PubMed ID: 3034169 [TBL] [Abstract][Full Text] [Related]
28. [CT image of the liver cancer after administration of SMANCS/lipiodol]. Maki S; Konno T; Iwai K; Tashiro S; Otsuka N; Yamasaki K; Mizutani J; Miyauchi Y; Maeda H; Yokoyama I Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1603-10. PubMed ID: 3015036 [TBL] [Abstract][Full Text] [Related]
29. [Our initial experience with SMANCS in TAE for liver cancer]. Fujita M; Inoue E; Kuroda C; Kasugai H; Sasaki Y; Nakano H; Imaoka S Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():105-8. PubMed ID: 9512697 [TBL] [Abstract][Full Text] [Related]
30. [Targeted chemotherapy of hepatocellular carcinoma with SMANCS/Lipiodol--how to use SMANCS/Lipiodol]. Konno T; Tabaru K; Isogai M; Nagamitsu A; Oda T Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():10-8. PubMed ID: 9512681 [TBL] [Abstract][Full Text] [Related]
31. [Combination of transcatheter arterial infusion of SMANCS and embolization (SMANCS-TAE) for hepatocellular carcinoma--second report]. Hirashima N; Itazu I; Nukaya H; Kimura H; Hasegawa I; Yoshimizu T; Nemoto S; Sakakibara K Gan To Kagaku Ryoho; 1998 May; 25(6):873-9. PubMed ID: 9617326 [TBL] [Abstract][Full Text] [Related]
32. [A case of giant hepatocellular carcinoma successfully treated by arterial administration of SMANCS]. Yajima Y; Miyazaki A; Miyasato S; Tomiya Y; Shibuya D; Ohira S; Sakurada H; Ishii K; Kinoshita T Gan To Kagaku Ryoho; 1996 Sep; 23(10):1325-9. PubMed ID: 8831747 [TBL] [Abstract][Full Text] [Related]
33. [Significance of arterial infusion of SMANCS-dissolved Lipiodol in therapeutic strategies for hepatocellular carcinoma]. Jin-no K Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():90-8. PubMed ID: 9512695 [TBL] [Abstract][Full Text] [Related]
35. Treatment of renal cell carcinoma with intra-arterial administration of SMANCS dissolved in Lipiodol. Noda S; Konno S; Tanaka J; Yamada M; Yoshitake N Anticancer Res; 1990; 10(3):709-15. PubMed ID: 2164351 [TBL] [Abstract][Full Text] [Related]
36. Successful arterial administration therapy of SMANCS for liver metastasis of malignant insulinoma. Igarashi H; Ito T; Ogoshi K; Kuroiwa T; Koyanagi S; Arita Y; Sumii T; Nawata H Pancreas; 1999 Aug; 19(2):207-10. PubMed ID: 10438170 [No Abstract] [Full Text] [Related]
37. Clinical evaluation of arterial administration of SMANCS in oily contrast medium for liver cancer. Tashiro S; Maeda H Jpn J Med; 1985 Feb; 24(1):79-80. PubMed ID: 2987585 [No Abstract] [Full Text] [Related]
38. [Comparative studies on the antitumor activities and side effects of segmental SMANCS/Lip-TAE with segmental SMANCS/Lip-TAI for hepatocellular carcinoma]. Matoba M; Okimura T; Yamamoto I Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():73-9. PubMed ID: 9512692 [TBL] [Abstract][Full Text] [Related]
39. [Efficiency of segmental SMANCS/Lip-TAE for hepatocellular carcinoma--comparative studies in the efficacy of segmental SMANCS/Lip-TAI]. Matoba M; Mitsuya T; Ichiyanagi K; Morita M; Kidani E; Ibe N; Tatsumi Y; Tamamura H; Nakagawa T; Okimura T; Yamamoto I Gan To Kagaku Ryoho; 1997 Jan; 24(1):37-42. PubMed ID: 9020943 [TBL] [Abstract][Full Text] [Related]
40. [Evaluation of hepatic artery occlusion after intra-arterial infusion of SMANCS in patients with hepatocellular carcinoma]. Sakaguchi T; Yoshimatsu S; Sagara K; Yamashita Y; Takahashi M Nihon Igaku Hoshasen Gakkai Zasshi; 1998 Oct; 58(12):700-4. PubMed ID: 9844406 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]